Eloralintide And Tirzepatide
A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity
Eli Lilly · Phase 1 · Completed · Enrollment 188
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Eloralintide and Tirzepatide-Cohorts A-D | Obesity or overweight | n/r | 26 | n/r | n/r |
| Eloralintide-Cohorts E and F | Obesity or overweight | n/r | 26 | n/r | n/r |